Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma
Clinical trial NCT01169532 · COMPLETED
Trial details
- NCT number
- NCT01169532
- Sponsor
- Fox Chase Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2014-03-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.